Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Observational

Role of MRI in the Early Diagnosis and Management of Acute Stroke and Its Impact on Turnaround Time in Emergency Settings

NCT07138768 · tracked via the Priya Life Science Egypt tracker
Phase
Observational
Started
2025-08-23
Last updated
2025-08-26

Condition(s) studied

Magnetic Resonance ImagingDiagnosisManagementAcute StrokeTurnaround TimeEmergency Settings

Investigational drug(s) / intervention(s)

Magnetic Resonance Imaging

Magnetic Resonance Imaging: Magnetic Resonance Imaging will be performed to all patients

Study summary

This study aims to evaluate the role of stroke protocol in the early diagnosis and management of acute stroke and its effect on turnaround time (TAT) in emergency settings.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age ≥18 years. * Both sexes. * Patients with acute stroke who are admitted to the emergency department. Exclusion Criteria: * Contraindications to magnetic resonance imaging (MRI) or computed tomography (CT). * Symptoms strongly suggestive of subarachnoid hemorrhage. * Initiation of antithrombotic or thrombolytic treatment before the completion of both scans. * Inability to complete both scans in time to allow thrombolytic treatment within three h of the onset of symptoms. * Uncontrollable hypertension. * Pregnant or lactating women.

Primary outcome measure(s)

  • Sensitivity of magnetic resonance imaging for acute stroke — Immediately post-procedure (Up to 1 hour)
    Sensitivity of magnetic resonance imaging for acute stroke will be recorded.

Trial sites (1)

FacilityCityRegionStatus
Tanta University Tanta El-Gharbia Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07138768 on ClinicalTrials.gov ↗ ← All trials in Egypt